Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy

Acknowledgements section was missing

Saved in:
Bibliographic Details
Published inClinical & translational oncology Vol. 22; no. 4; p. 621
Main Authors Passaro, A., Mancuso, P., Gandini, S., Spitaleri, G., Labanca, V., Guerini-Rocco, E., Barberis, M., Catania, C., Del Signore, E., de Marinis, F., Bertolini, F.
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.04.2020
Subjects
Author Correction
Medicine
Medicine & Public Health
Oncology
Online AccessGet full text

Cover

More Information
Summary:Acknowledgements section was missing
Bibliography:correction
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correction/Retraction-1
ObjectType-Feature-3
content type line 23
ISSN:1699-048X
1699-3055
DOI:10.1007/s12094-019-02198-5